Gut barrier evidence
Leaky Gut / Increased Intestinal Permeability:what the evidence shows.
Intestinal permeability is a real part of gut biology. That does not make “leaky gut syndrome” a validated catch-all diagnosis, and commercial permeability tests have important limitations.
Intestinal permeability is real physiology. “Leaky gut syndrome” is a much broader commercial label.
The intestinal barrier is selectively permeable: it allows nutrients and water to cross while limiting unwanted exposure to microbes and other luminal contents. Barrier function can change in recognised gastrointestinal disease.
Increased intestinal permeability has been studied in conditions including coeliac disease and inflammatory bowel disease. A 2025 review in Gut, for example, describes impaired barrier function as part of coeliac-disease pathophysiology. [1]
That is different from diagnosing a standalone “leaky gut syndrome” from a broad list of symptoms. A 2024 clinical review notes that leaky gut syndrome is not currently accepted as a formal medical diagnosis and that no validated blood or stool test can diagnose it as a general syndrome. [2]
Why can the same term cause confusion?
In research, intestinal permeability is a measurable biological property. In commercial wellness language, “leaky gut” is sometimes used to explain fatigue, headaches, brain fog, food reactions, skin symptoms, pain and many other complaints at once.
The evidence does not support using nonspecific symptoms alone to establish intestinal permeability as the cause. Those symptoms overlap with many recognised gastrointestinal, metabolic, neurological and mental-health conditions.
The clinically useful task is therefore to identify the actual symptom pattern and decide which conventional diagnoses or investigations are relevant before attaching one broad mechanism to everything.
Can a blood, stool or zonulin test diagnose “leaky gut”?
Not reliably as a general clinical diagnosis. The 2024 review of leaky gut syndrome describes substantial problems with direct-to-consumer testing, including commercial zonulin assays and stool panels. It concludes that no blood test currently exists to diagnose leaky gut syndrome and that stool testing marketed for the same purpose lacks established clinical utility. [2]
This does not mean intestinal-barrier research is meaningless. It means a research measurement or experimental biomarker is not automatically ready for direct-to-consumer diagnosis.
A useful clinical test needs analytical validity, a clinically interpretable result and a management decision that improves care. If a test cannot tell you what diagnosis is present or what treatment should change, the value of buying it is limited.
Which recognised gut conditions can affect barrier function?
Coeliac disease is one clear example. In susceptible people, gluten drives immune-mediated injury of the small intestine, and abnormal barrier function is part of the disease process. [1]
Inflammatory bowel disease and some other gastrointestinal disorders have also been studied in relation to barrier dysfunction. But the clinical priority remains diagnosing and treating the underlying disease, not treating “permeability” as a substitute diagnosis.
IBS can also involve altered gut physiology, but IBS, coeliac disease and inflammatory bowel disease are distinct conditions with different diagnostic and treatment pathways.
What should happen if you have bloating, diarrhoea or food-related symptoms?
Start with the symptom pattern. Duration, weight change, stool changes, bleeding, nocturnal symptoms, medication use, family history and previous investigations help determine the next step.
The gut health and persistent digestive symptoms guide explains the wider clinical assessment route. If testing is being considered, the functional medicine testing page explains why a test should answer a defined question rather than act as a fishing expedition.
Do not remove multiple food groups solely because a commercial “leaky gut” panel is abnormal. Restrictive diets can create nutritional and practical burdens, especially when the underlying diagnosis is still uncertain.
What is a more evidence-based way to think about gut-barrier symptoms?
- Use “intestinal permeability” as a physiological concept, not a catch-all diagnosis.
- Investigate recognised conditions when the symptom pattern warrants it.
- Do not assume direct-to-consumer zonulin or stool markers identify a validated syndrome.
- Treat established disease according to its evidence-based pathway.
- Be cautious with expensive supplement or elimination programmes built on unvalidated tests.
- Reassess if symptoms persist, change or develop alarm features.
A simple way to think about “leaky gut” claims
Start with the symptom, not the label. If you have bloating, pain or diarrhoea, ask what recognised conditions can cause that pattern. The answer may include IBS, coeliac disease, inflammatory bowel disease, infection, medicine effects or another cause.
Next, ask what the proposed test can prove. A test may measure one marker or one part of gut biology. That does not mean it can tell you why you are tired, why food causes symptoms or whether one treatment will help.
Then ask what happens after the result. If a “high permeability” result leads straight to a long supplement list or broad food restriction, ask whether that action is supported by evidence for your actual condition.
Finally, check whether a standard pathway has been missed. Coeliac blood tests, faecal calprotectin, endoscopy, imaging or another test may be appropriate in some cases. These tests are not chosen because they are more conventional. They are chosen when they answer a clear clinical question.
What does the research on intestinal permeability actually tell us?
Research shows that the gut barrier can change in disease. That is useful science. It helps researchers understand how the gut lining, immune system and microbes interact.
The harder question is whether measuring permeability in one person improves clinical care. A research marker can be real but still be a poor test for everyday diagnosis. It needs a reliable method, a useful reference range and a clear link to a treatment decision.
This gap explains why the phrase “leaky gut” can be both partly true and still misleading. The biology is real. The broad syndrome, the symptom lists and the commercial tests may go far beyond what the evidence can support.
A careful clinician can acknowledge the biology without making a diagnosis that has not been established.
What should treatment focus on?
Treatment should focus on the recognised condition when one is found. Coeliac disease has a defined diagnostic and dietary pathway. Inflammatory bowel disease has its own medical treatment. IBS has a different approach again.
If no clear diagnosis is found, symptom care can still be useful. Diet, bowel habit, medicines, sleep and stress can be reviewed without claiming that one barrier defect explains the whole problem.
Be careful with broad “gut-healing” programmes. A product may be useful for a separate reason, but it should not be sold as proof that the gut was leaking or that the barrier has now been repaired.
Good follow-up asks whether symptoms and function improve, whether nutrition remains adequate and whether new warning signs have appeared.
A plain-English decision guide
If you have gut symptoms, first ask whether they need a normal medical work-up. Start with the symptoms, how long they have been present and whether there are warning signs.
If a recognised condition is found, treat that condition. Coeliac disease, inflammatory bowel disease and IBS are not the same problem. They need different care.
If no clear cause is found, do not jump straight to a “leaky gut” label. Ask what has been ruled out and what still needs review. A normal test can still be useful because it can make some causes less likely.
If someone offers a permeability test, ask what the result can prove. Ask what a normal result means. Ask what an abnormal result changes. If the answer is vague, the test may not help you.
If the plan after testing is a long list of food bans and supplements, ask for the evidence behind each step. Do not assume that a costly plan is more precise.
How can food be handled safely while symptoms are being assessed?
Keep the diet as broad as you can unless a clinician has given a clear reason to restrict it. A very narrow diet can reduce fibre, calories, protein, vitamins and minerals.
If one food seems to trigger symptoms, write down what happens and when. This is more useful than removing many food groups at once. A dietitian can help when a structured elimination trial is needed.
Do not start a gluten-free diet before coeliac testing if coeliac disease is being considered, because removing gluten can affect the test pathway. Ask the clinician what to do first.
Food choices can help symptoms in some gut conditions. That does not prove the gut was “leaky” or that a barrier has been “sealed”. Keep the claim as narrow as the evidence.
Keep the next step simple
Start with what you can see and feel. Note pain, bloating, stool change and weight change. Note how long the problem has lasted.
Bring old test results if you have them. A normal old test can still help. It can show what has already been checked.
Ask one question at a time. Do I need a coeliac test? Do I need a stool test? Do I need a scan or scope? The answer depends on your symptoms.
If a commercial test is offered, ask what it can prove. Ask what happens if it is normal. Ask what happens if it is high. If both answers lead to the same supplement plan, the test may not be doing useful work.
Keep food as simple and varied as you can. Do not cut out many foods at once. If a diet trial is needed, agree the goal and review point first.
Most of all, do not let the “leaky gut” label stop a proper medical review. A clear diagnosis is more useful than a broad label.
What patients say about the consultation experience.
Reviews can describe communication and consultation experience. They do not prove that a test, supplement or treatment is effective.
Read patient reviews on Google
Individual reviews do not predict diagnosis, treatment response or outcome.
“patient, understanding and kind”
Google reviewer
“warm and compassionate bedside manner”
Google reviewer
“takes incredible care to get to know her patients”
Google reviewer
Common questions
Is “leaky gut syndrome” a recognised medical diagnosis?
Not as a standalone diagnosis in the way it is often marketed. Increased intestinal permeability is a real biological phenomenon and is studied in recognised diseases, but current clinical reviews distinguish that science from the broad commercial label “leaky gut syndrome”.
Can zonulin testing diagnose leaky gut?
Current evidence does not support commercial zonulin testing as a validated way to diagnose a general leaky-gut syndrome. Published reviews describe methodological problems with available assays and uncertain clinical interpretation, so an abnormal result should not be treated as a diagnosis by itself.
Can stool tests show that my gut is “leaky”?
Commercial stool panels sometimes include markers promoted as evidence of permeability, but current evidence does not establish a validated stool test for diagnosing leaky gut syndrome. The clinical question should remain whether a recognised gastrointestinal condition needs assessment.
Is intestinal permeability involved in coeliac disease?
Yes. Increased intestinal permeability is part of the pathophysiology studied in coeliac disease. That does not mean the same mechanism explains every case of bloating, fatigue or food sensitivity. Coeliac disease has its own diagnostic pathway and should be investigated on its own terms.
Should I follow an elimination diet to heal a leaky gut?
Not solely because an unvalidated permeability test is abnormal. Elimination diets can be appropriate for specific diagnosed conditions or short structured trials, but broad long-term restriction can reduce nutritional adequacy and make the underlying problem harder to assess.
When should digestive symptoms be medically assessed?
Persistent symptoms deserve assessment when they continue, change or affect weight and nutrition. Unexplained weight loss, gastrointestinal bleeding, persistent vomiting, anaemia or severe/worsening pain are examples of features that should not be managed through a commercial leaky-gut test alone.
Medical sources and further reading
- Gut: Coeliac disease and the intestinal barrier. 2025 review of intestinal-barrier dysfunction in coeliac disease.
- Lacy et al. 2024: Leaky Gut Syndrome: Myths and Management. Clinical review distinguishing intestinal permeability research from the unvalidated broad syndrome and commercial testing claims.
- NICE CG61: Irritable bowel syndrome. UK guideline for assessing and managing IBS rather than attributing nonspecific symptoms to an unvalidated syndrome.
Treat the recognised condition, not the marketing label.
Use symptoms, examination and validated diagnostic pathways to decide what needs investigation. Do not let an unvalidated permeability test replace a clinical diagnosis.